Jose Loor, DPM
Foot & Ankle Surgery · New York, NYNPI 1982906723
Payments from drug & device makers
Across 110 payments — averaging $64.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gotham Surgical Solutions & Devices, Inc.$3K
- Tenex Health Inc.$1K
- Amgen$832
- Paratek Pharmaceuticals, Inc.$555
- Orthofix Medical, Inc.$549
- Royal Biologics, Inc.$207
- plus $839 from 11 others
What the payments were for
- Travel & lodging$6249%
- Food & beverage$3,44448%
- Education$3,05043%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gotham Surgical Solutions & Devices, Inc. | 1 | $3,050 |
| Tenex Health Inc. | 6 | $1,086 |
| Amgen | 42 | $832 |
| Paratek Pharmaceuticals, Inc. | 32 | $555 |
| Orthofix Medical, Inc. | 14 | $549 |
| Royal Biologics, Inc. | 1 | $207 |
| Arthrosurface Incorporated | 2 | $180 |
| Nevro Corp. | 2 | $177 |
| Arteriocyte Medical Systems, Inc. | 1 | $100 |
| Medtronic | 1 | $87 |
| Forte Bio-pharma LLC | 1 | $77 |
| In2bones USA, LLC | 1 | $68 |
| Zimmer Biomet | 2 | $55 |
| Treace Medical Concepts, Inc. | 1 | $41 |
| Sandoz | 1 | $20 |
| Sebela Pharmaceuticals Inc. | 1 | $20 |
| Pfizer | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- RAYOS$375
- Fibrinet$207
- MaxxCell$207
- Maxx PRP$207
- HemiCAP MTP Resurfacing$178
- Omnia$142
- Physio-Stim Osteogenesis Stimulator$135
- Physio-Stim$133
- KRYSTEXXA$132
How this compares
$7,118 in reported general payments places this provider in the 75th percentile of 652 foot & ankle surgery providers in New York.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 98 | $168,487 |
| Tavaborole | 98 | $67,704 |
| Naproxen-Esomeprazole MagNaproxen/Esomeprazole Mag | 36 | $66,540 |
| Diclofenac Potassium | 16 | $38,700 |
| CrotanCrotamiton | 12 | $14,216 |
| Doxepin Hcl | 131 | $13,847 |
| Diclofenac Sodium ErDiclofenac Sodium | 131 | $10,333 |
| Fluconazole | 111 | $8,467 |
| Diclofenac Epolamine | 12 | $6,674 |
| Fluocinonide | 52 | $4,241 |
| Oxiconazole Nitrate | 14 | $4,206 |
| Naproxen Sodium | 20 | $1,902 |
| Clotrimazole | 30 | $1,816 |
| Ketoconazole | 31 | $746 |
| Terbinafine Hcl | 26 | $343 |
Paid to pharmacies, not to this prescriber.
Other foot & ankle surgery in New York
- Jonathan DelandNew York$4.1M
- Constantine DemetracopoulosNew York$888K
- Anne JohnsonNew York$815K
- Scott EllisNew York$644K
- John KennedyNew York$613K
- Stuart MogulNew York$131K
- Deena HornNew York$93K
- John DoolanNew York$87K
- Jason SnyderNew York$79K
- Meghan KellyNew York$75K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.